You know Bridge to Life for our unwavering commitment to quality and service. But we’re more than that. We’re focusing beyond product needs to be a true partner to the transplant community.
Pressurl: https://news.google.com/rss/articles/CBMikgFBVV95cUxPTmdGS1k3Y2h2THdlaXBEdjJIM0pYU3FBdjY2Yndvc0pRcko5TEpROTQ1QkxKeFh0VFEtOHg2Q3pPbEgxcU1Eamt2cXdhYWNyNjNlSUx5c09TOVlRZkVxZDJVVWE5N09Vblg5X1RROWpFZ3hCRFpBWXJHazZhSjhWSGpjODY0bmpQbzMtWWFxa1VRdw?oc=5 · headline: The United States Kidney Transplant Market Outlook, 2033 · publication: Grand View Researchgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi2gFBVV95cUxOWm1ZTkd6YnFSZ2JnLWRpVy1oMHVRQUdacUlPSEs0Vy1ITzlncmRGVFdJOGRxN1hocGJNTVpYVmdWeGFZUEM1Rl8zV2FMUjNnc3hKNFkzRzZqSVRYZW1McGk2NlJ2UTVzSXp5S2Jnd2JOOERVczQzWHUwSFJBelBKN1VYck9DMXRLVjk5QkRtUERLZnk2SnM4ay1lbFZELS1SVlY4QXE3c2hsV3RBeDRWTHl3WWNQRVhxMmgxUnRBUTVYUS1mVXc4TFQyZTA1bUZ0aF9kU0pZOE1VZw?oc=5 · headline: Bridge to Lifetm Secures FDA De Novo Clearance for VitaSmarttm Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers · publication: Lelezardgoogle_news · 10/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiswFBVV95cUxOSzJneVU2Q1BXWElaRnRYZjczMmIwWVB3LXQxU2lnMGIxaFNLSFBUY1NBNVkwcUpYbF9TYlExa1B2WHdVZjUxN2hDWVpRWTFPcU0xRHF6TTB4UEttTDhfbWRlVUtGOGtMWGlrSGdjVGFvMFVfazRFQ2R6X25tRFZzc1NQMUlSWUZtQmNEUG1NNzJmdWVNR1NzTmZRMDJPQ1NTY0huRmQtSmd5TGpqT2hRX3V2UQ?oc=5 · headline: Bridge to Life raises $110m to advance liver perfusion system’s rollout · publication: Medical Device Networkgoogle_news · 10/1/2026
Pressurl: https://news.google.com/rss/articles/CBMiqwFBVV95cUxQS1BJNE44ZWRBRmlCMm9LbTVFNktYR3BYY3d4QlFqWjd6dmFnWUVma2RYNUxGTEJJT1ZpZktZMUxDTV9SMF84NDI5ekNhZThGRGdPX3RJdXhGOGlOdThDTWR6OEYwSkllR2ZDQW9pQlVmTndmZWZXcTFVSDd1MWN5aFJMMjZPWEtkSVUxZk5wMXFhWk5SM3Z6S2FROEs5U1F5S2ZobUc0LTB5b00?oc=5 · headline: Bridge to Life Announces First Commercial Use of VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System by Major U.S. Transplant Center Following FDA Clearance, Signaling Early Physician Confidence · publication: Yahoo Finance
google_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMilgJBVV95cUxNWEgzRWI3SERZVTFLNXBQb05QMDlJaHFkVjR2UjhaT05XdHNPaFJNclBtbDlYVWhoY0FLOE8yUjI2MUs1RjVQeGdCMXM2RVJhUFd1aWRYZzF4REd4ekxzY21URHllemlobHc0emRYS2I3Q3Z2RmlQc2hIaUJvaUNEQUNEVGhxZERaZzI2Mkp1UEFDdDIzZXpKRXdlN20tLW1sN3ZyamVoQlBHbVRjYmYwV0tKR1ZOYnNGTG5HQXpzRWhJT0MtUm0xS0JmRk1kNl90RVV5QjF3MGVxb24xODkwYjlNaUFnMUMzUDd2OWxYV1ZrcHhSelAtbmVDbG9CQ0FBZ0ZjTGh6RjBPVGRUUWRwM0VvNWJaUQ?oc=5 · headline: Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond · publication: PR Newswiregoogle_news · 9/15/2026
Pressurl: https://news.google.com/rss/articles/CBMiiwFBVV95cUxQTXQ3U3U2bWJaWTNMd1BPVjlIel9McE56MlhtdU9NX0hyaG5TazdMN3NfdTNIV3V0Z0E3aUxaaWhqWHd6czJLRkprdUZuUUxCaUc3MFo3aTlkZzVYQXQ3Q2FVUTFiYmhpWjNfSEdINFVjWVZsZ1UxWUp4VFlINS1vT2xkMGdnRDRGQUtF?oc=5 · headline: Bridge to Life Raises $110M in Series C Funding · publication: FinSMEsgoogle_news · 9/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi9AFBVV95cUxOa080Vi1kYnVwaERkUDNhUmUwa2xqQUtTZmFBVTVNNkFOdFpNV21LLWZ0aUVVbFIyT0dSMkhna2t4X0xFZU9iZW9zdHVCUmFKcTFRbllrY1RkNjNCOUhZWlE0VFQ3NTdyR1JTeS1fd1lIZjhfMEt1bURyM1RIamtBSWJjeTdpc0RiYzRwajU4aTdrYW1KblpPMWtUZEFkS0FWOTd4MzZMYmpyWWVQRjFxenZ0bTE3OW1ORHJWNEZzbmxXTjV5YktjQU5ZcVc0LUJzNC1nWllfMC1lbU1USGhqOGc4RVRVUHZERWJOUUxnWDdlZkc2?oc=5 · headline: US: Bridge to Life completes US$110m Series C and debt financing to fuel the company’s VitaSmart launch · publication: Investors in Healthcaregoogle_news · 9/1/2026
Pressurl: https://news.google.com/rss/articles/CBMi6AFBVV95cUxQWjBRMkJNNGFOdUQ0MEVJMFRNbV9iYWFOQmp2T1FyRG1QcXZ0YTlwTjd5X1hyd3Z4c2UtdWg5d0ZrZVVQM25VdjRUN1JkX0RYVkVRZ3F5WXZzVHlPU25ua0YxOURMVlNGc3lYZlRobVZlQU1ERjJsZ19CYmZVNWR1aHhvRHpsSEtSWmNEOXJxa3NOQncxTENvZFZTUGJldzZqVFpKT21yYVkteVBTdFdXZ1dncjdkZVRJTjluUEdXeTVoUjV4Q043NURzYWlhNEJnWjQtNTJvdmZ6VzR1aVZBU3IwWElZczB2?oc=5 · headline: Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A. · publication: PR Newswiregoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMizwJBVV95cUxPMVZ6djA2aTJlXzhvbms3SHR2OGtzbHdyVkxsX0RtLTdLUnpLNlZuTUZMeVdCWG5aMTdnT2prRjR1YjB4UVdVZGREMW5qYjdFZzJrVmdEUko0U1k0WXBGMDNEUjgwcExXSVlObHU3YWVnY0ZUdkRCdHJSU2ExZ1h3dXhtQkJ2MnZBT2JNTkpPS1ZBNzhjSGx1YkM0d1RpUjBlM0lSR3ZWaTcxa0RwNndsVzlsTEtHeGFGQ2trb0N2bUxvbzVBaEo0LVBxQ0NJUi1KWW1DbGZCZFg5UUtOUkd1YklxT08wZ1ViOTA0azZTak8xLWNLTGRqZWNndTdxYkV3b0RDdzRzY2tYS3hzNFJkLTgxaXlhWE9DRjFOZEtraXFmVjY4QzAzcUZ4aG1UVktOd1RhcDNUbWdYaVE5UFJmRXNtWm9PaUxxZlNWSmNFMA?oc=5 · headline: First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE · publication: PR Newswiregoogle_news · 8/15/2026
Pressurl: https://news.google.com/rss/articles/CBMi5gFBVV95cUxPQjEyUXlDcVE4UlZjWGMwRzliT0duUmRaakRQNVpKUjRsZDltMlVGQzRXUTFoeUJPNzVjVEo0Vl9wMTFteGFqZ3ZTSVl1NUFjd18tSzZVdkNXdEdjTDNvTVkzMlp0ODQ1eTNJUUtrYndIUlBsem9oZlZWMVNzSDF1MmRQeGVnbGRBZzB2U19tLVktWExBamE4SUliZ3dGaWNtOUxjRzFHaXFLTWxkMHlWak1zV2JBbXlqYzAxb2dUUTB0cTdVUkx5QVE2U1hYQUY3bkx2X1pDd2lRWUtOX3doeDJQNGtwQQ?oc=5 · headline: Bridge to Life Ltd. Announces Early Results From Its Pivotal Bridge to HOPE Liver Clinical Trial · publication: PR Newswiregoogle_news · 8/15/2026